# Dose-dependent Effect of Rosuvastatin on Long-term Clinical Outcomes After PCI

> **NCT02859480** · PHASE4 · UNKNOWN · sponsor: **Korea University Anam Hospital** · enrollment: 300 (estimated)

## Conditions studied

- Coronary Artery Disease
- Coronary Disease
- Cardiovascular Diseases

## Interventions

- **DRUG:** Rosuvastatin 5mg
- **DRUG:** Rosuvastatin 20mg

## Key facts

- **NCT ID:** NCT02859480
- **Lead sponsor:** Korea University Anam Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-09
- **Primary completion:** 2019-06
- **Final completion:** 2019-12
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2016-08-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02859480

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02859480, "Dose-dependent Effect of Rosuvastatin on Long-term Clinical Outcomes After PCI". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02859480. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*